Journal of Andrology Testis Workshop 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print February 19, 2009, DOI:10.2164/jandrol.108.006270
Journal of Andrology, Vol. 30, No. 5, September/October 2009
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.108.006270

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/5/505    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilbey, Y. O.
Right arrow Articles by Somay, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilbey, Y. O.
Right arrow Articles by Somay, A.

Chemoprotective Effect of a Nuclear Factor-{kappa}B Inhibitor, Pyrrolidine Dithiocarbamate, Against Cisplatin-Induced Testicular Damage in Rats

YUSUF OZLEM ILBEY*, EMIN OZBEK*, ABDULMUTTALIP SIMSEK*, MUSTAFA CEKMEN{dagger}, ALPER OTUNCTEMUR* AND ADNAN SOMAY{ddagger}

From the Departments of * Urology and {ddagger} Pathology, Bezm-i Alem Valide Sultan Vak{iota}f Gureba Research and Education Hospital, Istanbul, Turkey; and {dagger} Department of Biochemistry, Kocaeli University, Istanbul, Turkey.

Correspondence to: Dr Yusuf Ozlem Ilbey, Bezm-i Alem Valide Sultan Vakif Gureba Research and Education Hospital, Department of Urology, Aksaray, Istanbul, Turkey (e-mail: ozlemyusufilbey{at}hotmail.com).



Abstract

The objective of this study was to evaluate inducible nitric oxide synthase (iNOS) and nuclear factor-{kappa}B inhibitor (NF-{kappa}B) expression and the potential chemoprotective effects of an NF-{kappa}B inhibitor, pyrrolidine dithiocarbamate (PDTC), against cisplatin-induced testicular damage in rats. Rats were divided into 4 equal groups: group 1, control; group 2, injected with cisplatin (CIS) for 5 days (7 mg/kg/day intraperitoneally [IP]); group 3, injected with PDTC alone; group 4, injected with CIS plus PDTC (100 mg/kg IP). Body and testicular weights, plasma testosterone levels, and histopathologic structure of the testicular tissue were determined. The iNOS and NF-{kappa}B activity were evaluated immunohistochemically by staining p65 to define NF-{kappa}B activity. Malondialdehyde (MDA), reduced glutathione (GSH), and nitric oxide (NO) levels and glutathione peroxidase (GSH-Px) activity were assessed in testicular tissue. Body and testicular weights, plasma testosterone levels, activity of GSH-Px, and GSH levels were all significantly decreased, whereas the levels of MDA and NO were significantly increased in rats of the CIS group. PDTC treatment increased plasma testosterone levels. A significant increase in GSH levels and GSH-Px activity and a decrease in MDA and NO levels in testicular tissue were observed in the CIS + PDTC group. Immunohistochemically, there was a marked staining for iNOS and NF-{kappa}B/p65 expression in rats injected with CIS compared with the control (P < .001). CIS caused irregular seminiferous tubules, reduction of seminiferous epithelial layers, significant arrest of maturation, and perivascular fibrosis. Moreover, PDTC administration to CIS-treated rats significantly prevented these histopathologic chances, as well. CIS induces iNOS expression through activation of NF-{kappa}B/p65, and CIS-induced testicular toxicity may be prevented by PDTC, which is a selective NF-{kappa}B inhibitor.

     Key words: Oxidative stress, antioxidant, testicular damage







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society of Andrology.